Array Biopharma, Inc. (ARRY) Reports Q1 EPS Loss of $0.06, Sales Beat Expectations
Go back to Array Biopharma, Inc. (ARRY) Reports Q1 EPS Loss of $0.06, Sales Beat Expectations| Array Biopharma, Inc. (NASDAQ: ARRY) | Delayed: 8.54 +0.54 (6.75%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.00 | 52 Week High | $7.27 | |||
| Open | $7.91 | 52 Week Low | $2.39 | |||
| Day High | $8.69 | P/E | N/A | |||
| Day Low | $7.91 | EPS | $-0.61 | |||
| Volume | 4,859,028 | |||||
